Curated GI articles July 1st, 2022: PE GI Solutions Joins SCA Health (owned by OptumCare) | Alternatives to private equity
Curated GI articles July 1st, 2022:
PE GI Solutions Joins SCA Health (owned by OptumCare) | Alternatives to private equity
PE GI Solutions Joins SCA Health (PE GI Solutions)
PE GI Solutions joins SCA Health (Surgical Care Affiliates), $2.5 billion ASC company. Note that SCA Health is part of OptumCare, which is part of United Healthcare.
Scope Forward Show: “It’s crazy that we record 4K videos with our iPhones but don’t capture data of our most precious asset – our body” (NextServices)
In this interview, Praveen Suthrum interviews Matt Schwartz CEO & Co-Founder at Virgo. If data is the new oil, could it be a new ancillary for GI?
Physician-owned management model: An alternative to private equity (Healio)
Michael Owens, MD, FASGE, physician and the director of digestive health at Pearl Incision shares his opinions on alternatives to private equity.
Private equity’s place in gastroenterology: 3 physicians’ viewpoints (Becker’s GI & Endoscopy)
The amount of private equity gastrointestinal groups grew to 68% last year and is projected to expand throughout 2022. Here is what three GIs said about this trend.
5 statistics making gastroenterologists nervous (Becker’s GI & Endoscopy)
From a rise in colorectal cancer cases to missed colonoscopy appointments, here are five numbers making gastroenterologists nervous.
FIT, Hemoglobin Together Can Rule Out CRC (GI & Endoscopy News)
In a population of almost 5,000 patients followed in a symptomatic patient referral pathway, the use of these two tests in combination correctly identified cancer in 99.96% of cases.
US Digestive Health CEO Jerry Tillinger wants GI leaders to embrace competition (Becker’s GI & Endoscopy)
Jerry Tillinger, CEO of U.S. Digestive Health in Exton discusses how competitors can be gastroenterology leaders’ greatest allies and more.
Health-Care Dealmaking Slows as US Inflation Hits Record High (Bloomberg Law)
Economic trends and supply chain issues point to a slowdown in transaction activity in many areas of the economy. Health-care dealmaking decreased in May under the pressure of record-setting inflation.
Why AI in GI? Why now? (Inside Perspectives)
Dr. Sravanthi Parasa and Dr. Prateek Sharma, M.D., practicing gastroenterologists, discuss how artificial intelligence can be applied in healthcare and why now is the time to learn about the possibilities.
Dr Christopher Thompson Discusses Innovative Treatment for Type 2 Diabetes and Obesity (AJMC)
Christopher Thompson, MD, director of endoscopy and codirector of the Center for Weight Management and Wellness at Brigham & Women’s Hospital, discusses duodenal jejunal bypass liner treatment and future innovations in gastroenterology.
Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity (UCLA)
The review adapts a framework for ethical AI/ML development and application to gastroenterology and hepatology such that clinical practice is advanced while minimising bias and optimising health equity.
Singaporean gut microbiome firm AMILI brings home $10.5M in Series A funding (Mobi Health News)
The company is building a huge multi-ethnic repository of microbiome data and samples. They are also developing diagnostics tests, predictive algorithms, and microbiome-modifying interventions.
The ACG Clinical Practice Guideline on Upper Gastrointestinal and Ulcer Bleeding Review (Medscape)
The guideline which offers 16 statements, are consolidated into five recommendations in this guideline update for the generalist.
AGA Presidential Plenary Focused on Eradicating Disparities in Gastroenterology (MedPage Today)
John M. Inadomi, MD, talks about “Don’t Talk — Act: The Relevance of DEI [Diversity, Equity, and Inclusion] to Gastroenterologists and Hepatologists and the Imperative for Action.”
Assessing the Clinical Robustness of Digital Health Startups: Cross-sectional Observational Analysis (JMIR)
The digital health sector has experienced rapid growth over the past decade. However, health care technology stakeholders lack a comprehensive understanding of clinical robustness and claims across the industry.
PreventionGenetics Receives FDA Approval for its Companion Diagnostic Genetic Test as a Class II Medical Device (PR Newswire)
Exact Sciences subsidiary PreventionGenetics announced that it has received clearance from the U.S. FDA for a companion diagnostic genetic test to identify patients for monogenic obesity therapy.
IBS guideline follow-up: try a low-FODMAP diet first (AGA)
AGA’s patient education can help patients successfully follow a low-FODMAP diet.
A Guide for Deprescribing Proton Pump Inhibitors (GI Insights)
Dr. Peter Buch and Dr. Laura Targownik, who’s the lead author of the American Gastroenterological Association’s Clinical Practice Update discuss about De-Prescribing of Proton Pump Inhibitors.
The urgent unmet need in IBD (Atomic IBD)
Patients have unequal access to expert care, latest medicines, nursing, dietary and psychological support. The article discusses key areas of urgent unmet need for IBD in 2022.
GISTs Mimic Gynecologic Diseases: A Case Series (Rare Disease Disorder)
Gastrointestinal stromal tumors (GISTs) may sometimes manifest as gynecologic diseases in some patients, according to a case series published in Diagnostics.
More Hot headlines in GI
ICYMI- SF Interview: Why GI doc left lucrative practice for startup (NextServices)
Cleveland Clinic hospital in Florida receives $5M for digestive center (Becker’s GI & Endoscopy)
7 gastroenterology practice openings in Q2 (Becker’s GI & Endoscopy)
Why primary care doctors are leaving revenue on the table (Medical Economics)
Researchers Uncover Factors Associated With NAFLD in Patients With IBD (GI & Endoscopy News)
Videos: Interviews with GI Leaders (NextServices)